Internal Medicine, Hematology & Oncology · Lake Charles, LA
NPI
1265558308
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
0
Medicare group memberships
Hospitals
5
Hospital affiliations
2770 3rd Ave # S350
Lake Charles, LA, 70601
Phone (337) 494-6800
Medicare paid, 2024
$70K
1,218 services
Medicare patients, 2024
356
Average age 75
Drug cost, 2024
$5.3M
2,009 prescriptions
Company payments, 2025
$3,798
From 43 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael A Bergeron was code 99213 (office e&m - established), 714 times for 281 patients. In total Michael A Bergeron billed 1,218 services in 9 codes, and Medicare paid $70K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-07-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 714 | 281 | $47.94 | $34K |
| 99213 Office E&M - Established | Office | 334 | 114 | $63.35 | $21K |
| 99214 Office E&M - Established | Facility | 37 | 27 | $70.68 | $2,615 |
| 99212 Office E&M - Established | Facility | 32 | 24 | $26.37 | $844 |
| 99204 Office E&M - New | Facility | 29 | 29 | $99.70 | $2,891 |
| 99205 Office E&M - New | Facility | 23 | 23 | $135.42 | $3,115 |
| 99204 Office E&M - New | Office | 14 | 14 | $123.84 | $1,734 |
By year: 2022 $64K for 978 services; 2023 $68K for 1,116 services; 2024 $70K for 1,218 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael A Bergeron prescribed most often to Medicare patients was Anastrozole, with 212 prescriptions and refills. In total Michael A Bergeron wrote 2,009 Medicare prescriptions that cost $5.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 212 | 316 | 39 | $2,170 |
| Letrozole Generic | 128 | 198 | 27 | $2,243 |
| Exemestane Generic | 87 | 117 | 17 | $6,313 |
| Levothyroxine Sodium Generic | 65 | 79 | Under 11 | $526 |
| Ondansetron Hcl Generic | 62 | 64 | 31 | $240 |
| Dexamethasone Generic | 54 | 63 | 16 | $1,903 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 48 | 48 | 14 | $1,655 |
| Valacyclovir Valacyclovir Hcl | 46 | 58 | Under 11 | $1,061 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 44 | 44 | 11 | $773 |
| Hydroxyurea Generic | 44 | 70 | Under 11 | $784 |
| Tramadol Hcl Generic | 44 | 44 | 11 | $95.49 |
| Fentanyl Generic | 43 | 43 | Under 11 | $1,948 |
| Revlimid Lenalidomide | 41 | 41 | Under 11 | $711K |
| Tamoxifen Citrate Generic | 41 | 69 | 13 | $1,087 |
| Ibrance Palbociclib | 41 | 41 | Under 11 | $668K |
Brand drugs: 430 claims; generic drugs: 1,579 claims; opioid claims: 240.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael A Bergeron $3,798 ($3,798 in general payments such as food, travel and fees) from 43 companies. The largest payer was Daiichi Sankyo Inc. with $275.
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. 4568.T | 9 | $275 |
| AstraZeneca Pharmaceuticals LP AZN | 13 | $272 |
| Janssen Biotech, Inc. JNJ | 10 | $250 |
| Novartis Pharmaceuticals Corporation NVS | 10 | $214 |
| Merck Sharp & Dohme LLC MRK | 4 | $201 |
| BeOne Medicines USA, Inc. ONC | 5 | $190 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 4 | $187 |
| Puma Biotechnology, Inc. PBYI | 6 | $180 |
| Stemline Therapeutics Inc. | 3 | $154 |
| Pfizer Inc. PFE | 7 | $139 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.